ASTRAZENECA PHARMACEUTICALS LP. ... Alvin EMORY, Appellant v. ... of the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12101 et seq. Moving for summary judgment, AstraZeneca urged that Emory's substantive ... In all, Emory bid unsuccessfully for approximately ten internal promotions over a 12-year period.
Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb ... 31 U.S.C. § 3729 et seq., and corresponding state laws, appeals the District Court's .... At all relevant times, BMS participated in Medicaid's Drug Rebate Program with ...
Apr 17, 2017 ... Astrazeneca Biopharmaceuticals, Inc. ... PLC; Astrazeneca, LP; and Astrazeneca Pharmaceuticals, LP (together, ... AstraZeneca, et al., No.
Oct 12, 2016 ... Janssen Pharmaceuticals, Inc., et al., Case No. .... distributed by AstraZeneca Pharmaceuticals LP; and Jardiance and Glyxambi, marketed by.
Green v. Kansas Department for Children and Families et al. Date: December 28, 2017 ..... Funk et al v. Pinnacle Health Facilities XXXII, LP et al. Date: August ..... Muathe et al v. Fleming et al .... Koon v. AstraZeneca Pharmaceuticals LP et al
Feb 11, 2015 ... AstraZeneca LP, a pharmaceutical manufacturer based in Delaware, has agreed to pay the government $7.9 million to settle ... DiMattia et al. v.
Welcome to AstraZeneca United States. Beginning its journey in 1953, AstraZeneca became one of the first pharmaceutical companies operating in the United ...
AstraZeneca, LP, et al., C.A. No. 08-5135 (E.D. Pa.): a Medicaid rebate fraud case which settled in 2015 for a total of $55.5 million against three pharmaceutical ...
Oct 26, 2015 ... Generic Name Osimertinib. Applicant Name AstraZeneca Pharmaceuticals LP ...... thoracic imaging in North American/European vs. Asian sites? ...... PK=PD models for oxcarbazepine”, J.R. Nedelman et al, Statist. Med. 2007; ...... Use O' Brien Fleming boundary for the interim analyses of OS. FDA also notes ...